IRADIMED CORP - Common Stock (IRMD) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
IRMD on Nasdaq
Shares outstanding
12,733,410
Price per share
$97.28
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
6,912,935
Total reported value
$491,933,058
% of total 13F portfolios
0%
Share change
-109,776
Value change
-$6,192,572
Number of holders
183
Price from insider filings
$97.28
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of IRADIMED CORP - Common Stock (IRMD) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Nine Ten Capital Management LLC 7.1% $45,223,826 905,926 Nine Ten Capital Management 31 Dec 2024
BlackRock, Inc. 3.9% $24,790,422 496,603 BlackRock, Inc. 31 Mar 2025

As of 30 Sep 2025, 183 institutional investors reported holding 6,912,935 shares of IRADIMED CORP - Common Stock (IRMD). This represents 54% of the company’s total 12,733,410 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of IRADIMED CORP - Common Stock (IRMD) together control 43% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
BlackRock, Inc. 8% 1,015,876 +5.6% 0% $72,289,752
Nine Ten Capital Management LLC 6.1% 771,384 -12% 14% $54,892,000
VANGUARD GROUP INC 4.4% 566,507 +0.98% 0% $40,312,639
RENAISSANCE TECHNOLOGIES LLC 3.8% 488,762 -0.62% 0.05% $34,780,304
Copeland Capital Management, LLC 3.4% 433,500 -5.3% 0.64% $30,847,919
GEODE CAPITAL MANAGEMENT, LLC 2.1% 266,339 +1.9% 0% $18,954,603
DIMENSIONAL FUND ADVISORS LP 1.7% 214,551 -0.41% 0% $15,266,386
STATE STREET CORP 1.5% 187,239 +5.6% 0% $13,323,927
GOLDMAN SACHS GROUP INC 1.2% 149,801 +4.2% 0% $10,659,839
ACADIAN ASSET MANAGEMENT LLC 1.1% 145,278 -5.8% 0.02% $10,334,000
NORTHERN TRUST CORP 1.1% 137,499 -4% 0% $9,784,429
MORGAN STANLEY 1% 127,202 +39% 0% $9,051,770
Ranger Investment Management, L.P. 0.94% 119,620 -44% 0.59% $8,512,159
Russell Investments Group, Ltd. 0.81% 103,594 -30% 0.01% $7,371,804
Bank of New York Mellon Corp 0.81% 103,232 -0.53% 0% $7,346,022
MILLENNIUM MANAGEMENT LLC 0.77% 98,184 -12% 0.01% $6,986,773
Uniplan Investment Counsel, Inc. 0.61% 77,314 -3.8% 0.54% $5,501,730
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.54% 68,488 +1.8% 0% $4,873,606
ENVESTNET ASSET MANAGEMENT INC 0.53% 67,020 -0.12% 0% $4,769,131
SHAKER INVESTMENTS LLC/OH 0.5% 63,199 +19% 1.8% $4,497,241
Bridge City Capital, LLC 0.47% 59,345 -1.4% 1.1% $4,222,990
ISTHMUS PARTNERS, LLC 0.46% 58,740 +2.4% 0.93% $4,179,938
Qube Research & Technologies Ltd 0.45% 56,826 +17% 0.01% $4,043,738
TWO SIGMA INVESTMENTS, LP 0.42% 53,647 +33% 0.01% $3,817,521
ALGERT GLOBAL LLC 0.4% 50,797 +88% 0.06% $3,615,000

Institutional Holders of IRADIMED CORP - Common Stock (IRMD) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 107,894 $10,558,702 +$3,895,254 $97.28 17
2025 Q3 6,912,935 $491,933,058 -$6,192,572 $71.16 183
2025 Q2 7,049,520 $421,491,084 +$6,336,537 $59.79 160
2025 Q1 6,961,071 $365,301,543 -$580,346 $52.48 167
2024 Q4 6,941,169 $381,769,809 +$9,196,245 $55.00 165
2024 Q3 6,745,205 $338,835,085 -$4,494,420 $50.29 143
2024 Q2 6,792,851 $298,497,413 +$3,015,641 $43.94 137
2024 Q1 5,551,666 $244,215,415 -$8,638,587 $43.99 89
2023 Q4 6,490 $308,081 +$103,979 $47.47 1
2023 Q3 6,101,541 $270,676,799 -$3,589,692 $44.37 113
2023 Q2 6,133,726 $292,922,643 +$17,028,448 $47.74 109
2023 Q1 5,780,603 $227,464,413 +$10,411,216 $39.35 90
2022 Q4 5,524,512 $156,284,026 -$3,285,363 $28.29 73
2022 Q3 5,601,095 $168,303,363 +$3,058,592 $30.06 78
2022 Q2 5,472,814 $185,749,258 +$683,692 $33.94 85
2022 Q1 5,361,283 $240,486,874 +$16,787,772 $44.84 98
2021 Q4 4,980,615 $229,993,125 +$6,734,057 $46.21 93
2021 Q3 4,725,000 $158,757,781 -$1,685,334 $33.59 70
2021 Q2 4,760,941 $140,129,293 +$2,007,017 $29.41 58
2021 Q1 4,728,606 $122,220,018 +$1,016,075 $25.77 51
2020 Q4 4,699,586 $107,170,220 +$4,635,505 $22.80 53
2020 Q3 4,498,571 $96,357,082 +$270,011 $21.38 60
2020 Q2 4,134,096 $95,964,212 +$10,571,291 $23.21 62
2020 Q1 4,081,296 $87,040,189 +$8,212,059 $21.35 66
2019 Q4 3,686,217 $86,185,753 +$10,098,851 $23.38 61
2019 Q3 3,028,102 $63,649,327 +$7,503,807 $21.02 56
2019 Q2 2,656,786 $54,328,507 +$717,022 $20.45 51
2019 Q1 2,582,142 $72,532,489 +$8,349,358 $28.09 61
2018 Q4 2,337,055 $57,160,517 -$188,978 $24.46 66
2018 Q3 2,241,761 $83,261,235 +$11,390,481 $37.15 67
2018 Q2 2,122,342 $44,036,752 +$4,966,735 $20.75 49
2018 Q1 1,710,580 $24,258,264 +$2,577,726 $14.13 34
2017 Q4 1,710,858 $25,938,559 +$2,552,446 $15.15 35
2017 Q3 1,459,006 $14,009,010 -$339,474 $9.60 26
2017 Q2 1,500,984 $12,902,009 -$2,637,731 $8.59 32
2017 Q1 1,794,685 $15,970,694 -$4,060,209 $8.90 44
2016 Q4 2,275,470 $25,256,786 -$7,713,205 $11.10 56
2016 Q3 2,605,006 $44,256,310 +$5,718,903 $16.99 60
2016 Q2 2,213,115 $48,157,183 -$10,185,907 $21.76 57
2016 Q1 2,833,006 $54,284,033 +$1,010,570 $19.16 64
2015 Q4 2,567,348 $71,960,026 +$36,457,882 $28.03 72
2015 Q3 1,286,850 $31,343,593 +$2,078,712 $24.36 45
2015 Q2 1,280,146 $29,788,794 +$11,200 $23.27 38
2015 Q1 1,300,907 $19,815,000 -$253,992 $15.23 19
2014 Q4 1,323,017 $17,067,000 -$360,499 $12.90 19
2014 Q3 1,372,532 $9,620,000 +$8,145,994 $7.01 16